DK156376C - Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug - Google Patents

Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug

Info

Publication number
DK156376C
DK156376C DK316485A DK316485A DK156376C DK 156376 C DK156376 C DK 156376C DK 316485 A DK316485 A DK 316485A DK 316485 A DK316485 A DK 316485A DK 156376 C DK156376 C DK 156376C
Authority
DK
Denmark
Prior art keywords
ibogain
drugs
medicine
preparation
treatment
Prior art date
Application number
DK316485A
Other languages
English (en)
Other versions
DK316485D0 (da
DK316485A (da
DK156376B (da
Inventor
Howard S Lotsof
Original Assignee
Howard S Lotsof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard S Lotsof filed Critical Howard S Lotsof
Publication of DK316485D0 publication Critical patent/DK316485D0/da
Publication of DK316485A publication Critical patent/DK316485A/da
Publication of DK156376B publication Critical patent/DK156376B/da
Application granted granted Critical
Publication of DK156376C publication Critical patent/DK156376C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK316485A 1983-11-18 1985-07-11 Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug DK156376C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/553,138 US4499096A (en) 1983-11-18 1983-11-18 Rapid method for interrupting the narcotic addiction syndrome
US55313883 1983-11-18
PCT/US1984/001851 WO1985002115A1 (en) 1983-11-18 1984-11-13 A rapid method for interrupting the narcotic addiction syndrome
US8401851 1984-11-13

Publications (4)

Publication Number Publication Date
DK316485D0 DK316485D0 (da) 1985-07-11
DK316485A DK316485A (da) 1985-07-11
DK156376B DK156376B (da) 1989-08-14
DK156376C true DK156376C (da) 1990-01-02

Family

ID=24208273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK316485A DK156376C (da) 1983-11-18 1985-07-11 Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug

Country Status (11)

Country Link
US (1) US4499096A (da)
EP (1) EP0163697B1 (da)
AU (1) AU576538B2 (da)
CA (1) CA1237986A (da)
DE (1) DE3482305D1 (da)
DK (1) DK156376C (da)
IE (1) IE58567B1 (da)
IL (1) IL73585A (da)
IT (1) IT1178249B (da)
NO (1) NO844573L (da)
WO (1) WO1985002115A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587243A (en) * 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the cocaine and amphetamine abuse syndrome
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
EP0279114B2 (en) * 1986-11-21 1995-08-23 Glaxo Group Limited Medicaments for the treatment or prevention of the withdrawal syndrome
US4857523A (en) * 1988-07-18 1989-08-15 Nda International, Inc. Rapid method for attenuating the alcohol dependency syndrome
US5629307A (en) * 1989-10-20 1997-05-13 Olney; John W. Use of ibogaine in reducing excitotoxic brain damage
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
WO1996003127A1 (en) * 1994-07-25 1996-02-08 Nda International, Inc. A method of treating chemical dependency in mammals and a composition therefor
WO1997005869A1 (en) * 1995-08-08 1997-02-20 Albany Medical College Ibogamine congeners
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
ES2224430T3 (es) 1997-09-04 2005-03-01 Novoneuron Inc Noribogaina en el tratamiento del dolor y de la toxicomania.
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US20030199439A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US20040266659A1 (en) * 2003-06-27 2004-12-30 Stephen LaBerge Substances that enhance recall and lucidity during dreaming
US20050251442A1 (en) * 2004-05-07 2005-11-10 Joseph Ficalora Consumer incentive system and business method
US8267851B1 (en) 2009-06-16 2012-09-18 James M Kroll Method and apparatus for electrically generating signal for inducing lucid dreaming
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
CA2806232A1 (en) 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US20130178618A1 (en) 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
WO2013112673A1 (en) 2012-01-25 2013-08-01 Demerx, Inc. Synthetic voacangine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
EP2934541A4 (en) 2012-12-20 2016-08-03 Demerx Inc SUBSTITUTED NORIBOGAIN
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
WO2016126272A1 (en) * 2015-02-04 2016-08-11 Robert Rand Rapid method of reducing motor and non-motor symptoms of parkinson's disease
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220008824A (ko) 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법
WO2021178691A1 (en) 2020-03-05 2021-09-10 The Trustees Of Columbia University In The City Of New York Ibogaine analogs as therapeutics for neurological and psychiatric disorders
IL298323B2 (en) 2020-05-20 2023-10-01 Univ Illinois A method for treating lysosomal storage disease using histatin peptides
CA3208525A1 (en) * 2021-02-17 2022-08-25 Dalibor Sames Oxa-ibogaine analogues for treatment of substance use disorders
CN119923278A (zh) 2022-08-26 2025-05-02 约翰霍普金斯大学 用于靶向递送迷幻治疗剂的树枝状大分子组合物
US20240100062A1 (en) 2022-09-14 2024-03-28 The Board Of Trustees Of The Leland Stanford Junior University Methods of Treatment With an Iboga Alkaloid
US12116372B1 (en) 2023-12-14 2024-10-15 William Allen Boulanger Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877229A (en) * 1959-03-10 Process for the manufacture of indoles

Also Published As

Publication number Publication date
IE58567B1 (en) 1993-10-06
EP0163697A1 (en) 1985-12-11
US4499096A (en) 1985-02-12
DK316485D0 (da) 1985-07-11
IE842932L (en) 1985-05-18
IL73585A (en) 1990-04-29
DK316485A (da) 1985-07-11
DK156376B (da) 1989-08-14
DE3482305D1 (de) 1990-06-28
IT8449184A0 (it) 1984-11-19
AU576538B2 (en) 1988-09-01
EP0163697B1 (en) 1990-05-23
EP0163697A4 (en) 1986-04-15
NO844573L (no) 1985-05-20
AU3674484A (en) 1985-06-03
IL73585A0 (en) 1985-02-28
IT8449184A1 (it) 1986-05-19
CA1237986A (en) 1988-06-14
IT1178249B (it) 1987-09-09
WO1985002115A1 (en) 1985-05-23

Similar Documents

Publication Publication Date Title
NO170834C (no) Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel
DK464383D0 (da) Medikamentadministreringsapparat
DK316485D0 (da) Anvendelse af ibogain til fremstilling af et medikament til behandling af det narkotiske misbrugssyndrom
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
DK390181A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til frmme af saarheling
DK166479C (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
FI824098A0 (fi) Terapeutiskt medel
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
FI833453A7 (fi) Terapeutiska medel
FI833454A7 (fi) Terapeutiska medel
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
DK95489A (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
RO86393A2 (ro) Medicament cu actiune vasculo-trombocitara
DK469487A (da) Laegemiddel til behandling af fedme
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
RO84026A2 (ro) Medicament oftalmic